Hjem › Multipelt myelom › Alabama › Mobile
Multipelt myelom kliniske forsøg i Mobile, AL
3 studier for Multipelt myelom søger deltagere på steder i og omkring Mobile (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
RekruttererFase 3
- Infirmary Health - Diagnostic & Medical Clinic (DMC), Mobile
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RekruttererFase 3
- Infirmary Cancer Care, Mobile
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RekruttererFase 3
- GSK Investigational Site, Mobile
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Mobile
- Ikke-småcellet lungecancer13 studier
- Hjertesvigt13 studier
- Lungecancer7 studier
- Brystkræft7 studier
- Ægstockræft7 studier
- Overvægt7 studier
- Kræft (alle typer)6 studier
- Melanom6 studier
- Småcellet lungekræft6 studier
- Kardiovaskulær sygdom6 studier
- Atrieflimmer5 studier
- Overvægt5 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.